ID   PC3-neo
AC   CVCL_D5ZR
DR   Wikidata; Q127383023
RX   PubMed=17575147;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for PC3-STEAP-1 (PubMed=17575147).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=17575147; DOI=10.1158/0008-5472.CAN-06-3849;
RA   Challita-Eid P.M., Morrison K., Etessami S., An Z.-L., Morrison K.J.M.,
RA   Perez-Villar J.J., Raitano A.B., Jia X.-C., Gudas J.M., Kanner S.B.,
RA   Jakobovits A.;
RT   "Monoclonal antibodies to six-transmembrane epithelial antigen of the
RT   prostate-1 inhibit intercellular communication in vitro and growth of
RT   human tumor xenografts in vivo.";
RL   Cancer Res. 67:5798-5805(2007).
//